Mexico approves the emergency use of the Russian-made Covid-19 vaccine Sputnik V.
The country’s authorities approved the emergency use of the vaccine on Tuesday. After knowing of its positive effects on the human body.
Given the limited supply of Covid-19 vaccines from a number of notable vaccine manufacturers, the Russian vaccine initiative will help South American countries sustain their efforts to continue their vaccination programs.
Earlier last year, Mexico was criticized for approving the use of Russian vaccines without extensive clinical trials.
An article was published Monday in the medical journal The Lancet, analyzing data from 2,000 people who took part in the third phase of the Sputnik V vaccine trial. The results indicate that two doses of Covid-19 are more than 91.6% effective.
Mexican President Andres Manuel Lopez Obrador said last week after a telephone conversation with Russian President Vladimir Putin that Russia had agreed to give his country 24 million doses of the Sputnik V vaccine.
More than 1.8 million people have been infected with the coronavirus in Mexico so far. About 160,000 died.
Mexico now ranks third in the world in the number of dead people. Only Brazil and the United States are above him.
Mexico has started mass vaccination since December 24. So far, the country has used vaccines developed by US pharmaceutical company Pfizer and its German partner BioNTech.
A vaccine made by AstraZeneca and Oxford Universities has already been approved there. Mexico has also signed a joint venture agreement with Argentina.
In addition to Mexico, more than a dozen countries have approved the use of the Sputnik V vaccine. These include Venezuela, Iran, South Korea, Argentina, Algeria, Tunisia and Pakistan.